Home
About
Directory
Promoted Listings
Purchase Data
Drug Pipelines
Data Licensing
Newsletter
Contact
C.R. Bard
is defunct.
Acquired by BD, Dec 2017, $24B
------------------
If you believe any of this information is incorrect, please
let us know
.